32. Jahreskongress Pharmazeutische Medizin
Berlin, 17. - 18.03.2016, Steigenberger Hotel
Dr. Seimetz: „Individualized therapies and immunotherapies: How can regulatory challenges be successfully managed?“
Dr. Dallmann: „Scientific Advice in the EU and the US: Practical experience and rules of the game on both sides of the Atlantic Ocean“